Cost of rapid covid-19 tests halved

COST OF RAPID COVID-19 TESTS HALVED AS GLOBAL INVESTMENT ENSURES AVAILABILITY OF HIGH VOLUMES FOR LOW- AND MIDDLE-INCOME COUNTRIES

The Foundation for Innovative New Diagnostics (FIND) and Unitaid, on behalf of the Access to COVID-19 Tools (ACT) Accelerator Diagnostics Pillar, announced today that the first contracts have been finalized, following an open call for Expressions of Interest (EOI) that was launched on 4 July 2020 to drive equitable access to fit-for-purpose antigen-detecting rapid diagnostic tests (Ag RDTs) for COVID-19.